Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Receivables: 2017-2025

Historic Receivables for Assembly Biosciences (ASMB) over the last 7 years, with Sep 2025 value amounting to $912,000.

  • Assembly Biosciences' Receivables was N/A to $912,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year change of. This contributed to the annual value of $43,000 for FY2023, which is 95.44% down from last year.
  • As of Q3 2025, Assembly Biosciences' Receivables stood at $912,000, which was up 2,020.93% from $43,000 recorded in Q1 2024.
  • In the past 5 years, Assembly Biosciences' Receivables registered a high of $1.2 million during Q3 2022, and its lowest value of $43,000 during Q4 2023.
  • In the last 3 years, Assembly Biosciences' Receivables had a median value of $342,000 in 2023 and averaged $411,400.
  • Per our database at Business Quant, Assembly Biosciences' Receivables skyrocketed by 180.95% in 2022 and then crashed by 95.44% in 2023.
  • Assembly Biosciences' Receivables (Quarterly) stood at $336,000 in 2021, then surged by 180.95% to $944,000 in 2022, then slumped by 95.44% to $43,000 in 2023, then slumped by 94.00% to $43,000 in 2024, then reached $912,000 in 2025.
  • Its Receivables stands at $912,000 for Q3 2025, versus $43,000 for Q1 2024 and $43,000 for Q4 2023.